Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gibson

Showing results (951-960 of 986) with videos related to

Pageof 99
Sort By:
Thorax|December 19, 2015
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summaryR Andres Floto, Kenneth N Olivier, Lisa Saiman, et al.
HGG Advances|February 7, 2022
Leveraging TOPMed imputation server and constructing a cohort-specific imputation reference panel to enhance genotype imputation among cystic fibrosis patientsQuan Sun, Weifang Liu, Jonathan D Rosen, et al.
Stroke|September 11, 2025
Preclinical Ischemic Stroke Multicenter Trials (PRISM) Collective Statement: Opportunities, Challenges, and Recommendations for a New EraCenk Ayata, Philip M Bath, Anna M Planas, et al.
HGG Advances|June 1, 2022
Accounting for population structure in genetic studies of cystic fibrosisHanley Kingston, Adrienne M Stilp, William Gordon, et al.
Brain : a Journal of Neurology|March 26, 2026
The prevalence of Lewy body pathology across nine international community-based cohortsLucy L Gibson, Claudia K Suemoto, Johannes Attems, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 21, 2022
Effects of Bardoxolone Methyl in Alport SyndromeBradley A Warady, Pablo E Pergola, Rajiv Agarwal, et al.
Science (New York, N.Y.)|May 1, 2025
Bespoke plant glycoconjugates for gut microbiota-mediated drug targetingWei Jen Ma, Changqing Wang, Jagatheeswaran Kothandapani, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation StrategyGilaad G Kaplan, Joseph W Windsor, Janet Crain, et al.
Croatian Medical Journal|December 19, 2008
Setting priorities in global child health research investments: guidelines for implementation of CHNRI methodIgor Rudan, Jennifer L Gibson, Shanthi Ameratunga, et al.
Kidney International Reports|April 14, 2020
Urinary Epidermal Growth Factor as a Marker of Disease Progression in Children With Nephrotic SyndromeDebbie S Gipson, Howard Trachtman, Anne Waldo, et al.
Pageof 99

Showing results (951-960 of 986) with videos related to

Sort By:
Pageof 99
Thorax|December 19, 2015
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summaryR Andres Floto, Kenneth N Olivier, Lisa Saiman, et al.
HGG Advances|February 7, 2022
Leveraging TOPMed imputation server and constructing a cohort-specific imputation reference panel to enhance genotype imputation among cystic fibrosis patientsQuan Sun, Weifang Liu, Jonathan D Rosen, et al.
Stroke|September 11, 2025
Preclinical Ischemic Stroke Multicenter Trials (PRISM) Collective Statement: Opportunities, Challenges, and Recommendations for a New EraCenk Ayata, Philip M Bath, Anna M Planas, et al.
HGG Advances|June 1, 2022
Accounting for population structure in genetic studies of cystic fibrosisHanley Kingston, Adrienne M Stilp, William Gordon, et al.
Brain : a Journal of Neurology|March 26, 2026
The prevalence of Lewy body pathology across nine international community-based cohortsLucy L Gibson, Claudia K Suemoto, Johannes Attems, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 21, 2022
Effects of Bardoxolone Methyl in Alport SyndromeBradley A Warady, Pablo E Pergola, Rajiv Agarwal, et al.
Science (New York, N.Y.)|May 1, 2025
Bespoke plant glycoconjugates for gut microbiota-mediated drug targetingWei Jen Ma, Changqing Wang, Jagatheeswaran Kothandapani, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation StrategyGilaad G Kaplan, Joseph W Windsor, Janet Crain, et al.
Croatian Medical Journal|December 19, 2008
Setting priorities in global child health research investments: guidelines for implementation of CHNRI methodIgor Rudan, Jennifer L Gibson, Shanthi Ameratunga, et al.
Kidney International Reports|April 14, 2020
Urinary Epidermal Growth Factor as a Marker of Disease Progression in Children With Nephrotic SyndromeDebbie S Gipson, Howard Trachtman, Anne Waldo, et al.
Pageof 99